Cargando…

Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study

BACKGROUND: Neurosteroids affect the balance between neuroexcitation and neuroinhibition but have been little studied in migraine. We compared the serum levels of pregnenolone sulfate, pregnanolone and estradiol in women with menstrually-related migraine and controls and analysed if a correlation ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Rustichelli, Cecilia, Bellei, Elisa, Bergamini, Stefania, Monari, Emanuela, Lo Castro, Flavia, Baraldi, Carlo, Tomasi, Aldo, Ferrari, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989028/
https://www.ncbi.nlm.nih.gov/pubmed/33757421
http://dx.doi.org/10.1186/s10194-021-01231-9
_version_ 1783668880962486272
author Rustichelli, Cecilia
Bellei, Elisa
Bergamini, Stefania
Monari, Emanuela
Lo Castro, Flavia
Baraldi, Carlo
Tomasi, Aldo
Ferrari, Anna
author_facet Rustichelli, Cecilia
Bellei, Elisa
Bergamini, Stefania
Monari, Emanuela
Lo Castro, Flavia
Baraldi, Carlo
Tomasi, Aldo
Ferrari, Anna
author_sort Rustichelli, Cecilia
collection PubMed
description BACKGROUND: Neurosteroids affect the balance between neuroexcitation and neuroinhibition but have been little studied in migraine. We compared the serum levels of pregnenolone sulfate, pregnanolone and estradiol in women with menstrually-related migraine and controls and analysed if a correlation existed between the levels of the three hormones and history of migraine and age. METHODS: Thirty women (mean age ± SD: 33.5 ± 7.1) with menstrually-related migraine (MM group) and 30 aged- matched controls (mean age ± SD: 30.9 ± 7.9) participated in the exploratory study. Pregnenolone sulfate and pregnanolone serum levels were analysed by liquid chromatography-tandem mass spectrometry, while estradiol levels by enzyme-linked immunosorbent assay. RESULTS: Serum levels of pregnenolone sulfate and pregnanolone were significantly lower in the MM group than in controls (pregnenolone sulfate: P = 0.0328; pregnanolone: P = 0.0271, Student’s t-test), while estradiol levels were similar. In MM group, pregnenolone sulfate serum levels were negatively correlated with history of migraine (R(2) = 0.1369; P = 0.0482) and age (R(2) = 0.2826, P = 0.0025) while pregnenolone sulfate levels were not age-related in the control group (R(2) = 0.04436, P = 0.4337, linear regression analysis). CONCLUSION: Low levels of both pregnanolone, a positive allosteric modulator of the GABAA receptor, and pregnenolone sulfate, a positive allosteric modulator of the NMDA receptor, involved in memory and learning, could contribute either to headache pain or the cognitive dysfunctions reported in migraine patients. Overall, our results agree with the hypothesis that migraine is a disorder associated with a loss of neurohormonal integrity, thus supporting the therapeutic potential of restoring low neurosteroid levels in migraine treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10194-021-01231-9.
format Online
Article
Text
id pubmed-7989028
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-79890282021-03-25 Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study Rustichelli, Cecilia Bellei, Elisa Bergamini, Stefania Monari, Emanuela Lo Castro, Flavia Baraldi, Carlo Tomasi, Aldo Ferrari, Anna J Headache Pain Short Report BACKGROUND: Neurosteroids affect the balance between neuroexcitation and neuroinhibition but have been little studied in migraine. We compared the serum levels of pregnenolone sulfate, pregnanolone and estradiol in women with menstrually-related migraine and controls and analysed if a correlation existed between the levels of the three hormones and history of migraine and age. METHODS: Thirty women (mean age ± SD: 33.5 ± 7.1) with menstrually-related migraine (MM group) and 30 aged- matched controls (mean age ± SD: 30.9 ± 7.9) participated in the exploratory study. Pregnenolone sulfate and pregnanolone serum levels were analysed by liquid chromatography-tandem mass spectrometry, while estradiol levels by enzyme-linked immunosorbent assay. RESULTS: Serum levels of pregnenolone sulfate and pregnanolone were significantly lower in the MM group than in controls (pregnenolone sulfate: P = 0.0328; pregnanolone: P = 0.0271, Student’s t-test), while estradiol levels were similar. In MM group, pregnenolone sulfate serum levels were negatively correlated with history of migraine (R(2) = 0.1369; P = 0.0482) and age (R(2) = 0.2826, P = 0.0025) while pregnenolone sulfate levels were not age-related in the control group (R(2) = 0.04436, P = 0.4337, linear regression analysis). CONCLUSION: Low levels of both pregnanolone, a positive allosteric modulator of the GABAA receptor, and pregnenolone sulfate, a positive allosteric modulator of the NMDA receptor, involved in memory and learning, could contribute either to headache pain or the cognitive dysfunctions reported in migraine patients. Overall, our results agree with the hypothesis that migraine is a disorder associated with a loss of neurohormonal integrity, thus supporting the therapeutic potential of restoring low neurosteroid levels in migraine treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10194-021-01231-9. Springer Milan 2021-03-23 /pmc/articles/PMC7989028/ /pubmed/33757421 http://dx.doi.org/10.1186/s10194-021-01231-9 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Short Report
Rustichelli, Cecilia
Bellei, Elisa
Bergamini, Stefania
Monari, Emanuela
Lo Castro, Flavia
Baraldi, Carlo
Tomasi, Aldo
Ferrari, Anna
Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study
title Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study
title_full Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study
title_fullStr Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study
title_full_unstemmed Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study
title_short Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study
title_sort comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989028/
https://www.ncbi.nlm.nih.gov/pubmed/33757421
http://dx.doi.org/10.1186/s10194-021-01231-9
work_keys_str_mv AT rustichellicecilia comparisonofpregnenolonesulfatepregnanoloneandestradiollevelsbetweenpatientswithmenstruallyrelatedmigraineandcontrolsanexploratorystudy
AT belleielisa comparisonofpregnenolonesulfatepregnanoloneandestradiollevelsbetweenpatientswithmenstruallyrelatedmigraineandcontrolsanexploratorystudy
AT bergaministefania comparisonofpregnenolonesulfatepregnanoloneandestradiollevelsbetweenpatientswithmenstruallyrelatedmigraineandcontrolsanexploratorystudy
AT monariemanuela comparisonofpregnenolonesulfatepregnanoloneandestradiollevelsbetweenpatientswithmenstruallyrelatedmigraineandcontrolsanexploratorystudy
AT locastroflavia comparisonofpregnenolonesulfatepregnanoloneandestradiollevelsbetweenpatientswithmenstruallyrelatedmigraineandcontrolsanexploratorystudy
AT baraldicarlo comparisonofpregnenolonesulfatepregnanoloneandestradiollevelsbetweenpatientswithmenstruallyrelatedmigraineandcontrolsanexploratorystudy
AT tomasialdo comparisonofpregnenolonesulfatepregnanoloneandestradiollevelsbetweenpatientswithmenstruallyrelatedmigraineandcontrolsanexploratorystudy
AT ferrarianna comparisonofpregnenolonesulfatepregnanoloneandestradiollevelsbetweenpatientswithmenstruallyrelatedmigraineandcontrolsanexploratorystudy